Cancer cells in the S components upregulated SOX4 and CEACAM5 and downregulated pro-inflammatory factors such as SCGB1A1 and SFTPC in comparison with cancer cells in the GG components (Figure 2B). The gene discussed is SCGB1A1; the disease is cancer.